Join the Early Access Program for ThruPLEX Tag-seq!
We are looking for participants in both academia and industry who have an interest in:
- Increasing the sensitivity and specificity of their data
- Evaluating a kit that produces high quality, tagged-libraries with an easy workflow
- Partnering with an innovative company to finalize a product
- Developing liquid biopsy assays to detect somatic mutations
- Discovering more information about the fetus from maternal blood
Rubicon Genomics reports robust Sales Growth in 2016 and announces Early Access Program for Thruplex® Tag-Seq KitsMore
Rubicon Genomics Licenses Commercialization Rights from SomaGenics for Its RealSeq®-AC Technology for High-Throughput Sequencing of Small RNA’sMore
ThruPLEX 12S (12 Rxn) Kit to be Discontinued on June 15, 2016More
Rubicon Genomics expands Asia distribution; 2016 AACR data presentation shows utility of ThruPLEX® Plasma-seq Cell-free NGS libraries from Liquid BiopsiesMore
What Our Customers Say
"Your ThruPLEX Plasma-seq Kit is the easiest to follow and has the most streamlined protocol (importantly with the fewest clean-up steps). We successfully made libraries from 1ng input in this trial."
"Our experience with the ThruPLEX library prep has been extremely positive. Both at Rubicon and in our hands it has proven able to generate high quality, diverse libraries from 10x less input than other kits we have used. For us this technology truly enables the study of samples that simply weren’t possible before adopting it.”
“Using PicoPLEX we can combine highly accurate chromosome screening, using array-CGH or SNP microarrays, with diagnosis of single gene disorders via PCR amplification plus mutation detection or again using SNP array.”